Senator Risa Hontiveros on Thursday, Nov. 4 said she is not backing down against her accusers who filed sedition charges against her and her staff before the Office of the Ombudsman over alleged bribery, saying she is happy to confront her accusers “before a court of law.” “I am happy to...
Presidential aspirant Senator Ronald “Bato” Dela Rosa on Tuesday said the Senate Blue Ribbon Committee’s hearings on the alleged anomalous transaction between the Pharmally Pharmaceutical Corporation and the Department of Budget and Management’s Procurement Services (DBM-PS) is already...
Senator Risa Hontiveros on Friday, Oct. 22 said executives of Pharmally Pharmaceutical Corporation should just produce the documents the Senate blue ribbon committee has ordered subpoenaed. Hontiveros issued the remark after Mohit Dargani, Pharmally’s corporate secretary and treasurer released a...
Outspoken private law practitioner Ferdinand Topacio on Wednesday, Oct. 20 chided anew the Senate Blue Ribbon Committee (BRC) as a “kangaroo court” out to cash in on the political mileage derived from the extended hearings on the overpriced COVID-19 supply scandal. Ferdinand Topacio Topacio,...
President Duterte has banned his Cabinet officials, among others, from attending the investigations of the Senator Richard Gordon-chaired Senate Blue Ribbon Committee. President Rodrigo Duterte (left) and Senator Richard Gordon (Photos from Malacañang and MANILA BULLETIN) A memorandum dated Oct....
The Pharmally Pharmaceutical Corporation official who earlier broke contact with the Senate after giving her testimony affirming the anomalies in the government’s procurement of COVID-19 pandemic supplies from their company showed up at the continuation of the Senate blue ribbon committee’s...
Opposition Senator Leila De Lima on Monday, Oct. 4 chided President Duterte for ordering members of the Philippine National Police (PNP) and the Armed Forces of the Philippines (AFP) to ignore the Senate’s subpoenas in its inquiry into the government’s procurement of overpriced COVID-19...
Krizle Grace Mago, an incorporator and former regulatory officer of embattled Pharmally Pharmaceuticals Corporation, on Monday, Oct. 4 retracted her statement in admitting before the Senate that the firm had “swindled” government, stressing that it was a “pressured response” to a question...
“Missing” Pharmally Pharmaceuticals Corp. executive Krizle Grace Mago was placed under “protective custody’ of the House of Representatives after presenting herself by her lonesome before the chamber’s sergeant-at-arms at around 6:30 pm on Friday, Oct. 1. Pharmally executive Krizle Mago...
Controversial Pharmally Pharmaceuticals Corporation executive Krizle Grace Mago on
Tuesday, Sept. 28 vowed to do her best “to continue to cooperate” with the ongoing congressional inquiry into the alleged overpricing of COVID-19 supplies delivered by her firm to government. In a statement...
The House of Representatives on Tuesday, Sept. 28 subpoenaed Krizle Grace Mago, an executive of the embattled Pharmally Pharmaceuticals Corporation, to appear before the chamber’s Committee on Good Government and Public Accountability on October 4. Rep. Michael Edgar Aglipay Signed by Speaker...
The House Committee on Good Government on Monday, Sept. 27 voted unanimously to subpoena Krizle Mago, regulatory affairs chief of Pharmally Pharmaceutical Corporation, after failing to testify during its inquiry into the reported overpricing of personal protective gears and other anti-COVID-19...
